Asset Management One
PBYI icon

Asset Management One’s Puma Biotechnology PBYI Stock Holding History

Asset Management One’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-135,587
Closed -$8.96M – 1155
2016
Q3 		$8.96M Sell
135,587
-36,620
-21% -$1.85M 0.13% 168
2016
Q2 		$5.22M Buy
172,207
+26,339
+18% +$823K 0.08% 292
2016
Q1 		$4.01M Buy
145,868
+66,480
+84% +$3M 0.06% 374
2015
Q4 		$6.25M Sell
79,388
-4,046
-5% -$318K 0.09% 254
2015
Q3 		$5.96M Buy
83,434
+1,269
+2% +$120K 0.09% 279
2015
Q2 		$9.33M Buy
82,165
+13,913
+20% +$2.52M 0.13% 201
2015
Q1 		$16.4M Buy
68,252
+18,667
+38% +$3.99M 0.2% 109
2014
Q4 		$9.48M Buy
49,585
+27,182
+121% +$6.03M 0.12% 216
2014
Q3 		$5.55M Buy
+22,403
New +$4.6M 0.08% 310

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Asset Management One's PBYI Position: Q4 2016 in Review

Asset Management One sold out of Puma Biotechnology (PBYI) in Q4 2016, closing a stake of 135,587 shares — an estimated $8.96M sold.

Asset Management One first reported a position in PBYI in Q3 2014 and held it in 9 quarters. The position peaked at $16.4M in Q1 2015. 128 funds tracked by Wall St. Rank hold PBYI as of Q4 2016.

  • Asset Management One reported no remaining Puma Biotechnology position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 135,587 Puma Biotechnology shares in Q4 2016, an estimated $8.96M.
  • Asset Management One first reported a position in Puma Biotechnology in Q3 2014 and held it in 9 quarters.
  • Asset Management One's Puma Biotechnology position peaked at $16.4M in Q1 2015.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.